Latest revenue
$1.42B
as of 2026-03-31
Latest net income
$48.9M
as of 2026-03-31
Net margin
3.4%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.44B
- Enterprise value
- $1.44B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $90.48
- 52-wk low
- $0.30
- Beta
- —
- Shares out
- 16.7M
5-year trend
What this company does
ITEM 1. Business Overview Our business is transforming healthcare by empowering the primary care physicians (“PCP”) to be the agents for change in the communities they serve. We believe that PCPs, with their intimate patient-physician relationships, are best positioned to drive meaningful change in quality, cost and patient experience when provided with the right infrastructure and payment model. Through our combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, we believe we are poised to revolutionize healthcare for seniors across communities throughout the United States (“U.S.”). We believe our…
AI summary unavailable — showing raw filing excerpt
Generated from AGL's filing dated 2026-02-25
Key risks
Table of Contents ITEM 1A. Risk Factors Summary Risk Factors. Our business is subject to a number of risks, including risks that may prevent us from achieving our business objectives or may adversely affect our business, financial condition, cash flows, and results of operations that you should consider before making a decision to invest in our common stock. These risks include, but are not limited to, the following: Risks Related to Our Business •our history of net losses and the expectation that our expenses will increase in the future; •failure to identify and develop successful new geographies, physician partners and payors, or execute upon our growth initiatives; •success in executing…
AI summary unavailable — showing raw filing excerpt
Generated from AGL's filing dated 2026-02-25
Profitability
Operating margin
-7.8%
62.0%Net margin
-6.6%
53.7%Return on equity
-55.2%
39.2%Return on assets
-30.8%
105.2%Leverage
Debt / equity
2.68×
64.5%Long-term debt / equity
0.07×
51.8%Debt / assets
72.8%
17.5%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $1.42B | -7.3% | $48.9M | +303.9% | 3.4% |
Q4 2025 2025-12-31 | $1.57B | +3.1% | $-201.0M | -90.0% | -12.8% |
Q3 2025 2025-09-30 | $1.44B | -1.1% | $-110.2M | +6.3% | -7.7% |
Q2 2025 2025-06-30 | $1.39B | -5.9% | $-92.3M | -200.7% | -6.6% |
Q1 2025 2025-03-31 | $1.53B | -4.5% | $12.1M | +299.7% | 0.8% |
Q4 2024 2024-12-31 | $1.52B | — | $-105.8M | — | -6.9% |
Q3 2024 2024-09-30 | $1.45B | +27.6% | $-117.6M | -274.1% | -8.1% |
Q2 2024 2024-06-30 | $1.48B | +38.7% | $-30.7M | -4120.4% | -2.1% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Misc Health & Allied Services, NEC · SIC 8090
Your notes
Keep private notes on AGL — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$352.0K
Insider selling
$0
Net activity
+$352.0K
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns AGL
Institutional value
$1.2M
Total shares held
114.0K
Distinct holders
2
-191 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 107.8K | $1.2M | -215.8K (-66.7%) | Trimmed |
| 2 | IFP Advisors, Inc | 6.2K | $2.0K | -1.6K (-20.6%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once AGL's latest filing finishes processing.